In brief, I13 possesses a significant inhibitive effect on the cell proliferation of CML cells harboring T315I-mutated BCR-ABL and wild-type BCR-ABL by inducing cell differentiation. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.